Methicillin-resistant Staphylococcus aureus on orthopaedic wards
- 1 June 2006
- journal article
- Published by British Editorial Society of Bone & Joint Surgery in The Journal of Bone and Joint Surgery. British volume
- Vol. 88-B (6) , 812-817
- https://doi.org/10.1302/0301-620x.88b6.17544
Abstract
We examined the rates of infection and colonisation by methicillin-resistant Staphylococcus aureus (MRSA) between January 2003 and May 2004 in order to assess the impact of the introduction of an MRSA policy in October 2003, which required all admissions to be screened. Emergency admissions were treated prophylactically and elective beds ring-fenced. A total of 5594 admissions were cross-referenced with 22 810 microbiology results. The morbidity, mortality and cost of managing MRSA-carrying patients, with a proximal fracture of the femur were compared, in relation to age, gender, American Society of Anaesthesiologists grade and residential status, with a group of matched controls who were MRSA-negative. In 2004, we screened 1795 of 1796 elective admissions and MRSA was found in 23 (1.3%). We also screened 1122 of 1447 trauma admissions and 43 (3.8%) were carrying MRSA. All ten ward transfers were screened and four (40%) were carriers (all p < 0.001). The incidence of MRSA in trauma patients increased by 2.6% per week of inpatient stay (r = 0.97, p < 0.001). MRSA developed in 2.9% of trauma and 0.2% of elective patients during that admission (p < 0.001). The implementation of the MRSA policy reduced the incidence of MRSA infection by 56% in trauma patients (1.57% in 2003 (17 of 1084) to 0.69% in 2004 (10 of 1447), p = 0.035). Infection with MRSA in elective patients was reduced by 70% (0.56% in 2003 (7 of 1257) to 0.17% in 2004 (3 of 1806), p = 0.06). The cost of preventing one MRSA infection was £3200. Although colonisation by MRSA did not affect the mortality rate, infection by MRSA more than doubled it. Patients with proximal fractures of the femur infected with MRSA remained in hospital for 50 extra days, had 19 more days of vancomycin treatment and 26 more days of vacuum-assisted closure therapy than the matched controls. These additional costs equated to £13 972 per patient. From this experience we have been able to describe the epidemiology of MRSA, assess the impact of infection-control measures on MRSA infection rates and determine the morbidity, mortality and economic cost of MRSA carriage on trauma and elective orthopaedic wards.Keywords
This publication has 22 references indexed in Scilit:
- Effect of comorbidities and postoperative complications on mortality after hip fracture in elderly people: prospective observational cohort studyBMJ, 2005
- THE IMPACT OF INFECTION AFTER TOTAL HIP ARTHROPLASTY ON HOSPITAL AND SURGEON RESOURCE UTILIZATIONJournal of Bone and Joint Surgery, 2005
- Infection of the surgical site after arthroplasty of the hipThe Journal of Bone and Joint Surgery. British volume, 2005
- Factors associated with mortality and functional disability after hip fracture: an inception cohort studyOsteoporosis International, 2004
- Use of perioperative mupirocin to prevent methicillin-resistant Staphylococcus aureus (MRSA) orthopaedic surgical site infectionsJournal of Hospital Infection, 2003
- Results of Periprosthetic Hip and Knee Infections Caused by Resistant BacteriaClinical Orthopaedics and Related Research, 2002
- Predictors of outcome following hip fracture. Admission time predicts length of stay and in-hospital mortalityInjury, 2002
- Risk of death from methicillin‐resistant Staphylococcus aureus bacteraemia: a meta‐analysisThe Medical Journal of Australia, 2001
- Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals: Report of a combined working party of the British Society for Antimicrobial Chemotherapy, the Hospital Infection Society and the Infection Control Nurses AssociationJournal of Hospital Infection, 1998
- The cost of infection in surgical patients: a case-control studyJournal of Hospital Infection, 1993